Literature DB >> 29072953

Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls.

Nathan J Charles1, Daniel F Boyer1.   

Abstract

Mixed-phenotype acute leukemia (MPAL) is a heterogeneous category in the World Health Organization classification that comprises acute leukemias with discrete admixed populations of myeloid and lymphoid blasts ("bilineal") or with extensive coexpression of lymphoid and myeloid markers in a single blast population ("biphenotypic"). Flow cytometric findings suggestive of MPAL are often met with consternation by pathologists and oncologists alike, owing to unfamiliarity with the disease and uncertainty about how MPAL fits into established paradigms for treatment of acute leukemia. The purpose of this review is to explain the diagnostic criteria for MPAL, summarize its biological and clinical features, and address common diagnostic pitfalls of these unusual leukemias.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29072953     DOI: 10.5858/arpa.2017-0218-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  17 in total

1.  Novel inhibitors of the histone methyltransferase DOT1L show potent antileukemic activity in patient-derived xenografts.

Authors:  Florian Perner; Jayant Y Gadrey; Yijun Xiong; Charles Hatton; Benjamin K Eschle; Andreas Weiss; Frédéric Stauffer; Christoph Gaul; Ralph Tiedt; Jennifer A Perry; Scott A Armstrong; Andrei V Krivtsov
Journal:  Blood       Date:  2020-10-22       Impact factor: 22.113

2.  Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.

Authors:  Xiaoli Mi; Gabriel Griffin; Winston Lee; Sanjay Patel; Robert Ohgami; Chi Young Ok; Sa Wang; Julia T Geyer; Wenbin Xiao; Mikhail Roshal; Jacqueline S Garcia; Lewis B Silverman; Stephen E Sallan; Jon C Aster; Marian H Harris; Olga K Weinberg
Journal:  Am J Hematol       Date:  2018-09-26       Impact factor: 10.047

3.  Multiparametric Flow Cytometry in Mixed Phenotype Acute Leukemia.

Authors:  Sindhura Lakshmi Koulmane Laxminarayana; Nishika Madireddy; Chethan Manohar; Karthik Udupa
Journal:  Indian J Hematol Blood Transfus       Date:  2019-02-13       Impact factor: 0.900

4.  A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.

Authors:  Andrei V Krivtsov; Kathryn Evans; Jayant Y Gadrey; Benjamin K Eschle; Charlie Hatton; Hannah J Uckelmann; Kenneth N Ross; Florian Perner; Sarah N Olsen; Tara Pritchard; Lisa McDermott; Connor D Jones; Duohui Jing; Ali Braytee; Diego Chacon; Eric Earley; Brian M McKeever; David Claremon; Andrew J Gifford; Heather J Lee; Beverly A Teicher; John E Pimanda; Dominik Beck; Jennifer A Perry; Malcolm A Smith; Gerard M McGeehan; Richard B Lock; Scott A Armstrong
Journal:  Cancer Cell       Date:  2019-12-09       Impact factor: 31.743

5.  A paradigm shift: lineage switch from T-ALL to B/myeloid MPAL.

Authors:  Asish Rath; Tribikram Panda; Rishi Dhawan; Jasmita Dass; Manoranjan Mahapatra; Ganesh Kumar Viswanathan
Journal:  Blood Res       Date:  2021-03-31

Review 6.  Chromatin Complexes Maintain Self-Renewal of Myeloid Progenitors in AML: Opportunities for Therapeutic Intervention.

Authors:  Hannah J Uckelmann; Scott A Armstrong
Journal:  Stem Cell Reports       Date:  2020-06-18       Impact factor: 7.765

7.  Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome.

Authors:  Hyun Gyung Lee; Hee Jo Baek; Ho Sung Kim; Soo Min Park; Tai Ju Hwang; Hoon Kook
Journal:  Blood Res       Date:  2019-03-21

8.  Clinical Characteristics And Outcome Of Biphenotypic Acute Leukemia: 10 Case Reports And Literature Review.

Authors:  Jifeng Yu; Yingmei Li; Haizhou Xing; Yue Pan; Hui Sun; Dingming Wan; Yanfang Liu; Xinsheng Xie; Chong Wang; Ling Sun; Kai Sun; Zhongxing Jiang
Journal:  Cancer Manag Res       Date:  2019-10-31       Impact factor: 3.989

9.  Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia.

Authors:  Lindsey E Montefiori; Sonja Bendig; Zhaohui Gu; Xiaolong Chen; Petri Pölönen; Xiaotu Ma; Alex Murison; Andy Zeng; Laura Garcia-Prat; Kirsten Dickerson; Ilaria Iacobucci; Sherif Abdelhamed; Ryan Hiltenbrand; Paul E Mead; Cyrus M Mehr; Beisi Xu; Zhongshan Cheng; Ti-Cheng Chang; Tamara Westover; Jing Ma; Anna Stengel; Shunsuke Kimura; Chunxu Qu; Marcus B Valentine; Marissa Rashkovan; Selina Luger; Mark R Litzow; Jacob M Rowe; Monique L den Boer; Victoria Wang; Jun Yin; Steven M Kornblau; Stephen P Hunger; Mignon L Loh; Ching-Hon Pui; Wenjian Yang; Kristine R Crews; Kathryn G Roberts; Jun J Yang; Mary V Relling; William E Evans; Wendy Stock; Elisabeth M Paietta; Adolfo A Ferrando; Jinghui Zhang; Wolfgang Kern; Torsten Haferlach; Gang Wu; John E Dick; Jeffery M Klco; Claudia Haferlach; Charles G Mullighan
Journal:  Cancer Discov       Date:  2021-06-08       Impact factor: 39.397

10.  Rapid diagnosis of mixed phenotype acute leukemia after identifying a blood histogram abnormality.

Authors:  Rie Saito; Hisayuki Yokoyama; Kuniaki Meguro; Yusuke Ohba; Yoshihiko Izumi; Shinichiro Takahashi
Journal:  Pract Lab Med       Date:  2018-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.